A model to explain the pharmacological effects of snake venom phospholipases A2

This publication has 122 references indexed in Scilit:

• Toxicity domain in presynaptically toxic phospholipase A2 of snake venom
  Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1987
• Specific binding of three neurotoxins with phospholipase A2 activity to synaptosomal membrane preparations from the guinea pig brain
  Protein Journal, 1986
• Selective modification of tyrosine-68 in β1-bungarotoxin from the venom ofBungarus multicinctus (Taiwan banded krait)
  Protein Journal, 1986
• Cardiotoxic effects of venom phospholipase A2 are not due to phospholipid hydrolytic products
  Life Sciences, 1984
• Potent platelet aggregation inhibitor from Trimeresurus gramineus snake venom
  Biochimica et Biophysica Acta (BBA) - General Subjects, 1983
• Effect of methylation of histidine-48 on some enzymatic and pharmacological activities of snake venom phospholipases A2
  Life Sciences, 1983
• Basic phospholipase A2 from Naja nigricollis snake venom: Phospholipid hydrolysis and effects of electrical and contractile activity of the rat heart
  Toxicology and Applied Pharmacology, 1982
• The morphology of rat soleus neuromuscular junctions treated in vitro with purified β-bungarotoxin
  Brain Research, 1980
• Deenergization of nerve terminals by β-bungarotoxin
  Biochemistry, 1978
• The effect of phospholipases and proteases on the binding of γ-aminobutyric acid to junctional complexes of rat cerebellum
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 1976